Log in
A sustained joint research partnership with Biocompatibles UK Ltd has stimulated innovation underpinning the company's product development pipeline. Products include a family of soft contact lenses, enhanced medical device coatings, and novel treatments for liver cancer. Innovative enhancements, such as the unique non-biofouling nature of the company's ocular and cardiovascular devices and the practical utility of its drug eluting therapies for targeting liver malignancies, have delivered improved clinical performance and differentiated these products from those of competitors in the same markets. The company's continuing success in developing innovative medical technology products was recognised by the sale of Biocompatibles UK for £177m in 2011.